Lupin launches antiviral medication Molnulup for COVID-19 treatment in India

Molnupiravir has been given emergency use authorisation by the DCGI for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation.

|Jan 07, 2022, 13:24:43 IST

New Delhi: Drugmaker Lupin on Friday said it has launched antiviral medication Molnupiravir under the brand name Molnulup in the country for the treatment of COVID-19.Molnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation."The approval for Molnulup is timely as India is again experiencing an upward spike in COVID-19 incidences. In the past two years since COVID-19 has emerged, there is a need for an oral antiviral medicine that can be prescribed by the healthcare practitioners and then taken by the patients conveniently at home," Lupin President - India Region Formulations (IRF) - Rajeev Sibal said in a statement.Through the company's strong distribution network, Molnulup would be readily made available at pharmacies pan India to meet patient demand, he added.Internationally, Molnupiravir is an oral antiviral that has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) for the treatment of mild-to-moderate cases of COVID-19 in adults.Administered orally, Molnupiravir inhibits the replication of SARS-CoV-2, the causative agent of COVID-19.Pre-clinical and clinical data have shown Molnupiravir to be effective against the most common SARS-CoV-2 variants, including Gamma, Delta, and Mu variants.

10,000 steps a day is not enough: Top doctor explains the role of timing

Walking 10,000 steps a day is beneficial, but experts say timing matters. Short walks after meals and breaking up long periods of sitting may be more effective for blood sugar control and overall metabolic health

3 min read

What happens when you stop drinking tea for 30 days? Doctor explains the effects

Thinking of quitting tea for a month? Experts explain how cutting out caffeine can affect your body, from withdrawal symptoms in the first week to better sleep and improved iron absorption over time.

2 min read

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases

3 min read

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.